Learn More
Apexbio Technology LLC GNF-7 839706-07-9 25mg

Supplier: Apexbio Technology LLC B603325
GNF-7 (CAS 839706-07-9) is a small molecule type II kinase inhibitor that selectively targets the T315I mutant form of Bcr-Abl a constitutively active tyrosine kinase implicated in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia In vitro GNF-7 exhibits potent growth inhibitory effects in Colo205 SW620 and TrkC-Ba/F3 cell lines with IC50 values of 0 005 0 001 and 0 008 M respectively while displaying minimal activity on normal HEK293T cells In vivo GNF-7 reduces disease burden and improves survival in mouse leukemia models and selectively suppresses NRAS-dependent leukemia cells GNF-7 is valuable for research into kinase inhibitor resistance and targeted leukemia therapies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.